Oslo Børs – Resolution of transfer of listing from Euronext Growth to Oslo Børs – Gentian Diagnostics ASA

23. Jun 2021 | 1 min read

Oslo Børs has resolved to admit the shares in Gentian Diagnostics ASA to listing
on Oslo Børs.

It is stipulated that the company prior to the first day of admission to trading
must satisfy the listing requirements on Oslo Børs.

The President and CEO of Oslo Børs determines the first day of listing, no later
than 22 August 2021.

You may also read


Feb 12, 2026 - Ole Sørlie

Gentian Diagnostics: Key information relating to the proposed cash dividend

Moss, 12 February 2026 The Board of Directors of Gentian Diagnostics ASA proposes a dividend of NOK 0.60 per..

Read more

Feb 11, 2026 - Ole Sørlie

Update on the development of the NT-proBNP assay

Gentian Diagnostics ASA announces an update on the development of its NT proBNP assay. Recent investigations..

Read more

Feb 11, 2026 - Ole Sørlie

Gentian Diagnostics: Fourth quarter 2025 report

Moss, 11 February 2026 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic..

Read more